US Broker Ratings

Masimo Corporation (MASI) Stock Analysis: Navigating the Healthcare Sector with Steady Growth and Innovation

Masimo Corporation (MASI), a prominent player in the healthcare sector, is carving out a significant niche in the medical devices industry. With a market capitalization of..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Exploring the 91% Potential Upside in RNA Therapeutics

Atrium Therapeutics, Inc. (NASDAQ: RNA) presents a compelling investment opportunity for those willing to navigate the inherently volatile landscape of biotechnology. With a market capitalization of..

Charles River Laboratories (CRL) Stock Analysis: Harnessing a 17.67% Potential Upside in the Healthcare Sector

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a formidable player in the healthcare sector, specializing in diagnostics and research. With its broad range of..

TransMedics Group, Inc. (TMDX) Stock Analysis: Unveiling a 73.9% Potential Upside with a Revolutionary Medical Device

Investors seeking growth opportunities in the healthcare sector may want to closely examine TransMedics Group, Inc. (NASDAQ: TMDX). As a pioneering force in medical technology, TransMedics..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A 52% Potential Upside in a Booming Biotech Market

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a beacon of innovation in the biotechnology sector, with a market capitalization of $39.39 billion. Headquartered in Cambridge, Massachusetts,..

Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with a 22.93% Potential Upside

Baxter International Inc. (NYSE: BAX), a seasoned player in the healthcare sector, has long been a trusted provider of medical instruments and supplies. Headquartered in Deerfield,..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Biotech Powerhouse with 27.85% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) stands as a beacon of innovation in the biotechnology industry, specifically targeting RAS-addicted cancers with its precision oncology therapies. With a..

Repligen Corporation (RGEN): Investor Outlook Reveals 45.62% Potential Upside in Bioprocessing Innovator

Repligen Corporation (NASDAQ: RGEN) stands as a formidable player in the healthcare sector, specifically within the realm of medical instruments and supplies. With a market capitalization..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 7.81% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may want to turn their attention to Integer Holdings Corporation (NYSE: ITGR), a key player in the medical devices..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring a Potential 11.49% Upside

Bausch + Lomb Corporation (NYSE: BLCO) stands as a prominent player in the global healthcare sector, specializing in medical instruments and supplies with a particular focus..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating a 22.72% Potential Upside in the Diagnostics & Research Sector

Mettler-Toledo International, Inc. (NYSE: MTD), a key player in the Diagnostics & Research industry, presents an intriguing opportunity for investors seeking exposure in the healthcare sector...

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 19.67% Potential Upside in the Medical Device Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a key player in the healthcare sector specializing in medical devices, presents a promising opportunity for investors with a potential..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Evaluating the 10.25% Potential Upside in a Challenging Market

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a key player in the biotechnology sector, is drawing investor attention with its innovative approach to treating rare diseases. With a..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a 105% Potential Upside in Biotech Innovation

Vaxcyte, Inc. (NASDAQ: PCVX) is capturing the attention of investors with its promise of substantial growth in the biotechnology sector. With a market capitalization of $7.65..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 12.56% Upside Potential for Investors

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, specifically within the medical devices industry, offers individual investors a compelling opportunity with a..

Revvity, Inc. (RVTY) Stock Report: Analyzing Potential Upside and Analyst Consensus

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, operates within the dynamic diagnostics and research industry. With a market capitalization of $11.29 billion, the..

BrightSpring Health Services, Inc. (BTSG) Stock Analysis: Riding the Healthcare Wave with a Promising 10.40% Upside

BrightSpring Health Services, Inc. (BTSG) represents a compelling opportunity for investors focusing on the dynamic healthcare sector. With a market capitalization of $10.63 billion, this Louisville,..

Tempus AI, Inc. (TEM) Stock Analysis: Exploring the 38.92% Potential Upside for Investors

Tempus AI, Inc. (NASDAQ: TEM) is carving out a niche within the healthcare sector through its innovative healthcare technology solutions. With a market capitalization of $8.95..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A 51% Upside Potential in the Biotech Space

BridgeBio Pharma, Inc. (NASDAQ: BBIO) stands out in the biotechnology sector with an impressive market capitalization of $13.2 billion. Positioned within the healthcare industry, this biopharmaceutical..

Guardant Health, Inc. (GH) Stock Analysis: Unveiling a 36% Upside Potential in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH), a leader in the precision oncology space, is capturing the attention of investors with its innovative approach to diagnostics and research...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds